429 related articles for article (PubMed ID: 17471309)
21. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.
Moon SO; Kim W; Sung MJ; Lee S; Kang KP; Kim DH; Lee SY; So JN; Park SK
Mol Pharmacol; 2006 Jul; 70(1):112-9. PubMed ID: 16614140
[TBL] [Abstract][Full Text] [Related]
23. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
Blaschke S; Koziolek M; Schwarz A; Benöhr P; Middel P; Schwarz G; Hummel KM; Müller GA
J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
[TBL] [Abstract][Full Text] [Related]
24. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
25. Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS.
Guo X; Pan Y; Xiao C; Wu Y; Cai D; Gu J
Int J Rheum Dis; 2012 Jun; 15(3):322-9. PubMed ID: 22709495
[TBL] [Abstract][Full Text] [Related]
26. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
27. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.
Kobayashi T; Okamoto S; Iwakami Y; Nakazawa A; Hisamatsu T; Chinen H; Kamada N; Imai T; Goto H; Hibi T
Inflamm Bowel Dis; 2007 Jul; 13(7):837-46. PubMed ID: 17285595
[TBL] [Abstract][Full Text] [Related]
28. Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA).
Yoon BR; Yoo SJ; Choi Yh; Chung YH; Kim J; Yoo IS; Kang SW; Lee WW
PLoS One; 2014; 9(10):e109775. PubMed ID: 25329467
[TBL] [Abstract][Full Text] [Related]
29. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance.
Niederer F; Ospelt C; Brentano F; Hottiger MO; Gay RE; Gay S; Detmar M; Kyburz D
Ann Rheum Dis; 2011 Oct; 70(10):1866-73. PubMed ID: 21742641
[TBL] [Abstract][Full Text] [Related]
30. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
31. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.
Nanki T; Imai T; Nagasaka K; Urasaki Y; Nonomura Y; Taniguchi K; Hayashida K; Hasegawa J; Yoshie O; Miyasaka N
Arthritis Rheum; 2002 Nov; 46(11):2878-83. PubMed ID: 12428227
[TBL] [Abstract][Full Text] [Related]
32. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
Zhang X; Wei H; Wang H; Tian Z
Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
[TBL] [Abstract][Full Text] [Related]
33. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
[TBL] [Abstract][Full Text] [Related]
36. Role of ADAM-17, p38 MAPK, cathepsins, and the proteasome pathway in the synthesis and shedding of fractalkine/CX₃ CL1 in rheumatoid arthritis.
Jones BA; Riegsecker S; Rahman A; Beamer M; Aboualaiwi W; Khuder SA; Ahmed S
Arthritis Rheum; 2013 Nov; 65(11):2814-25. PubMed ID: 23897050
[TBL] [Abstract][Full Text] [Related]
37. Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.
Klosowska K; Volin MV; Huynh N; Chong KK; Halloran MM; Woods JM
Clin Exp Immunol; 2009 May; 156(2):312-9. PubMed ID: 19302240
[TBL] [Abstract][Full Text] [Related]
38. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
39. Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis.
Rana AK; Li Y; Dang Q; Yang F
Int Immunopharmacol; 2018 Dec; 65():348-359. PubMed ID: 30366278
[TBL] [Abstract][Full Text] [Related]
40. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
